A new study published in the British Journal of Cancer promises to open up new avenues toward swifter diagnosis of colorectal cancer by identifying two potential biomarkers for the early detection of the disease.

Despite progress over recent decades, colorectal cancer remains one of the most deadly cancers worldwide. A cancer biomarker is a molecule whose presence – or absence – in tissue may indicate that tumors are developing. Haan and colleagues examined the detailed analysis of 800 tests of tissue samples from patients at various stages of colorectal cancer and from healthy individuals.

READ FULL ARTICLE Curated publisher From Medical News Today